Hemobrás
Blood & Organ Banks · Brazil · 201-500 Employees
View Company Info for Free
Overview
Headquarters
15 Quadra 1 Projecao E Ed Central Park A...Phone Number
+55 6133276523Website
www.hemobras.gov.brRevenue
$58.1 MillionIndustry
About Hemobrás
Hemobrás Org Chart
Is Hemobrás your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Hemobrás is spiking on competitors!
Earning: See what the market has to say on Hemobrás recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Hemobrás has new funding data
Product Launch: Get notified when Hemobrás launches new products
Click to see if Hemobrás had a recent Job posting/layoffs
Hemobrás, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Hemobrás
Check if Hemobrás has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Hemobrás is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Hemobrás is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Hemobrás.
Hemobrás Tech Stack
A closer look at the technologies used by Hemobrás
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hemobrás
Hemobrás is a Brazilian public company dedicated to researching, developing, and producing hemoderivatives and biotechnological medicines primarily for the Unified Health System (SUS). The company plays a crucial role in the national pharmaceutical industry by reducing external dependency and improving the quality of life for patients across Brazil... Read More